AR and breast carcinoma: As two key pathways regulating both normal development and tumorigenesis in hormone-responsive prostate and mammary glands, the context-dependent interplay of AR and WNT signaling pathways provides a unique opportunity to explore therapeutic options for treating prostate and breast cancers, particularly when under the setting of therapeutic resistance.